ASPI vs XYL · rev $23.8M vs P/E 27, rev $4.46B
ASP Isotopes Inc. Common Stock (ASPI) versus Xylem Inc (XYL) — a side-by-side from cached financials, not a winner call.
ASP Isotopes Inc. Common Stock (ASPI) is a chemicals company listed on US.
Xylem Inc (XYL) is a specialty industrial machinery company listed on NYSE.
Latest reported ASPI revenue for 2025-12-31 was $23.8M. Net income was -$159.8M. Revenue was up 475.5% from 2024-12-31 to 2025-12-31. ASPI currently screens at market cap $620.7M.
Latest reported XYL revenue for 2026-06-30 was $4.46B. Net income was $456.0M. XYL currently screens at market cap $26.22B and trailing P/E 27.4.
ASPI currently screens at market cap $620.7M. XYL currently screens at market cap $26.22B and trailing P/E 27.4.
Not investment advice. Open the ASPI and XYL stock pages for the full models.
Not investment advice.